High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer’s Disease-Causing Mutations | Zendy

Andrea Sturchio | Zendy; Alok Dwivedi | Zendy; Tarja Malm | Zendy; Matthew J. A. Wood | Zendy; Roberto Cilia | Zendy; Jennifer Sharma | Zendy; Emily J. Hill | Zendy; Lon S. Schneider | Zendy; Neill R. GraffRadford | Zendy; Hiroshi Mori | Zendy; Georg Nübling | Zendy; Samir EL Andaloussi | Zendy; Per Svenningsson | Zendy; Kariem Ezzat | Zendy; Alberto J. Espay | Zendy

Open Access

High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer’s Disease-Causing Mutations

Author(s) -

Andrea Sturchio,

Alok Dwivedi,

Tarja Malm,

Matthew J. A. Wood,

Roberto Cilia,

Jennifer Sharma,

Emily J. Hill,

Lon S. Schneider,

Neill R. GraffRadford,

Hiroshi Mori,

Georg Nübling,

Samir EL Andaloussi,

Per Svenningsson,

Kariem Ezzat,

Alberto J. Espay

Publication year - 2022

Publication title -

journal of alzheimer s disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.677

H-Index - 139

eISSN - 1875-8908

pISSN - 1387-2877

DOI - 10.3233/jad-220808

Subject(s) - dementia , psen1 , medicine , pittsburgh compound b , clinical dementia rating , alzheimer's disease , standardized uptake value , cognitive decline , oncology , poisson regression , amyloid (mycology) , cerebrospinal fluid , psychology , pathology , disease , positron emission tomography , amyloid precursor protein , neuroscience , population , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research